New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For OREX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 26, 2015
08:21 EDTOREXOrexigen Contrave sales encouraging, says RBC Capital
Subscribe for More Information
07:22 EDTOREXOrexigen Contrave off to strong start, says JMP Securities
Subscribe for More Information
February 25, 2015
06:33 EDTOREXOrexigen reports Q4 EPS 0c, consensus 21c
Subscribe for More Information
February 24, 2015
09:03 EDTOREXUltragenyx adds Orexigen CEO to board
Ultragenyx Pharmaceutical (RARE) announced the appointment of Michael Narachi to the company's board, effective February 20. Narachi, President and CEO and a director of Orexigen Therapeutics (OREX), will serve as an independent director to Ultragenyx.
08:10 EDTOREXOrexigen resumed with an Outperform at Leerink
Target $8.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use